King Richard Insider Trades

Insider Trading History

Track insider trading activity for King Richard. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Spruce Biosciences
Spruce Biosciences SPRB
Chief Executive Officer
Holding Value $119k 2,230 shares
Last Trade
Jun 30, 2021 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$24.4k 2,230 shares
$10.93
$53.17
Spruce Biosciences
Spruce Biosciences SPRB
Chief Executive Officer
Holding Value $8.24M 155,000 shares
Last Trade
Jan 28, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.11M 155,000 shares
$20.08
$53.17
Spruce Biosciences
Spruce Biosciences SPRB
Chief Executive Officer
Holding Value $0 0 shares
Last Trade
Oct 08, 2020 Sale
No data
No data
$53.17
Adamas Pharmaceuticals
Adamas Pharmaceuticals ADMS
Chief Operating Officer
Holding Value $402k 48,856 shares
Last Trade
Jun 21, 2018 Sale (Open Market)Shares sold on the open market or in a private sale.
$63.7k 2,501 shares
$25.48
$8.22
Adamas Pharmaceuticals
Adamas Pharmaceuticals ADMS
Chief Operating Officer
Holding Value $543k 66,000 shares
Last Trade
Mar 06, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.69M 66,000 shares
$25.66
$8.22
Adamas Pharmaceuticals
Adamas Pharmaceuticals ADMS
Chief Operating Officer
Holding Value $326k 39,661 shares
Last Trade
Feb 28, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$251k 10,000 shares
$25.07
$8.22
Adamas Pharmaceuticals
Adamas Pharmaceuticals ADMS
Chief Operating Officer
Holding Value $1.39M 168,750 shares
Last Trade
May 05, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.94M 168,750 shares
$17.40
$8.22
Acelrx Pharmaceuticals
Acelrx Pharmaceuticals ACRX
Director
Holding Value $116k 134,567 shares
Last Trade
Mar 02, 2014 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$2.65M 11,599 shares
$228.60
$0.86
Acelrx Pharmaceuticals
Acelrx Pharmaceuticals ACRX
Director
Holding Value $151k 175,000 shares
Last Trade
Feb 04, 2014 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$36.2M 175,000 shares
$206.80
$0.86
Acelrx Pharmaceuticals
Acelrx Pharmaceuticals ACRX
Director
Holding Value $436k 507,057 shares
Last Trade
Feb 05, 2013 Sale (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$53.8M 507,057 shares
$106.20
$0.86
Acelrx Pharmaceuticals
Acelrx Pharmaceuticals ACRX
President And CEO
Holding Value $226k 262,214 shares
Last Trade
Feb 13, 2012 Sale (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$15.7M 262,214 shares
$60.00
$0.86
Acelrx Pharmaceuticals
Acelrx Pharmaceuticals ACRX
Chief Executive Officer
Holding Value $109k 126,957 shares
Last Trade
Jun 09, 2011 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$328k 3,500 shares
$93.80
$0.86
Acelrx Pharmaceuticals
Acelrx Pharmaceuticals ACRX
President And CEO
Holding Value $106k 123,457 shares
Last Trade
Mar 02, 2011 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$8.52M 123,457 shares
$69.00
$0.86
Acelrx Pharmaceuticals
Acelrx Pharmaceuticals ACRX
President And CEO
Holding Value $99.1k 115,208 shares
Last Trade
Mar 02, 2011 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$7.95M 115,208 shares
$69.00
$0.86
Acelrx Pharmaceuticals
Acelrx Pharmaceuticals ACRX
President And CEO
Holding Value $0 0 shares
Last Trade
Feb 10, 2011 Sale
No data
No data
$0.86

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up